Swathi M.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Swathi M. has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Gururaj A.
Department of Pharmacy Practice, Bapuji College of Pharmacy: Bapuji Pharmacy College Affiliated to Rajiv Gandhi University of Health Sciences, Davangere, India
1 shared publicationIsatrin J. Vadakkiniath
Department of Pharmacy Practice, Bapuji College of Pharmacy: Bapuji Pharmacy College Affiliated to Rajiv Gandhi University of Health Sciences, Davangere, India
1 shared publicationManjusha S.
Department of Pharmacy Practice, Bapuji College of Pharmacy: Bapuji Pharmacy College Affiliated to Rajiv Gandhi University of Health Sciences, Davangere, India
1 shared publication
Latest Publications
- 1 January 2024
- Published by SAGE Publications in Viral Immunology
- Vol. 37 (1) , 12-15
Arexvy: A Comprehensive Review of the Respiratory Syncytial Virus Vaccine for Revolutionary Protection
The respiratory syncytial virus (RSV) is a major cause of acute lower respiratory tract infection in children and poses a significant risk to older adults. Developing a vaccine against RSV has been a priority, and the recently approved Arexvy vaccine has shown promise in preventing lower respiratory tract disease (LRTD) caused by RSV in individuals aged 60 years and older. This comprehensive review discusses the history of RSV, challenges in vaccine development, and the mechanism of action of Arexvy. The efficacy and safety of the vaccine are explored based on phase 3 clinical trial, demonstrating its effectiveness in preventing RSV-associated LRTD. The most common adverse reactions reported include injection site pain, fatigue, myalgia, headache, and arthralgia. Ongoing research focuses on the long-term effectiveness of Arexvy, including the need for booster doses and its impact on reducing RSV-associated hospitalizations. The potential of Arexvy to lessen the burden of RSV-related illnesses, particularly in vulnerable populations, is highlighted, emphasizing the importance of widespread immunization efforts and accessibility to this groundbreaking vaccine.
- 1 January 2024
- Published by SAGE Publications in Viral Immunology
- Vol. 37 (1) , 12-15
Arexvy: A Comprehensive Review of the Respiratory Syncytial Virus Vaccine for Revolutionary Protection
The respiratory syncytial virus (RSV) is a major cause of acute lower respiratory tract infection in children and poses a significant risk to older adults. Developing a vaccine against RSV has been a priority, and the recently approved Arexvy vaccine has shown promise in preventing lower respiratory tract disease (LRTD) caused by RSV in individuals aged 60 years and older. This comprehensive review discusses the history of RSV, challenges in vaccine development, and the mechanism of action of Arexvy. The efficacy and safety of the vaccine are explored based on phase 3 clinical trial, demonstrating its effectiveness in preventing RSV-associated LRTD. The most common adverse reactions reported include injection site pain, fatigue, myalgia, headache, and arthralgia. Ongoing research focuses on the long-term effectiveness of Arexvy, including the need for booster doses and its impact on reducing RSV-associated hospitalizations. The potential of Arexvy to lessen the burden of RSV-related illnesses, particularly in vulnerable populations, is highlighted, emphasizing the importance of widespread immunization efforts and accessibility to this groundbreaking vaccine.
- Top Cited PapersOpen Access
- 16 August 2023
- Published by Springer Nature in Middle East Current Psychiatry
- Vol. 30 (1) , 1-14
Prevalence and correlates of stress, anxiety, and depression in patients with chronic diseases: a cross-sectional study
Background: Many chronic diseases, including diabetes, heart disease, cancer, and respiratory problems, can lead to emotional distress, anxiety, and depression among patients. Likewise, psychological conditions such as anxiety and depression can elevate the risk of developing chronic diseases. The objective of the study was to examine the prevalence of stress, anxiety, and depression in individuals with chronic diseases, as well as to identify the chronic disease with the highest prevalence among all chronic conditions and the factors associated with stress, anxiety, and depression. Results: In our study, the prevalence rate of stress, anxiety, and depression in patients having chronic diseases was found to be 68.7%, 51.1%, and 58.8%, respectively. The chronic diseases which are included in this study are cardiovascular diseases, metabolic disorders, cancer, respiratory disorders, degenerative disorders, chronic kidney disease, and chronic liver disorders. Among these diseases, cardiovascular disease patients were found to have the highest prevalence of stress, anxiety, and depression. The psychosocial determinants that can trigger stress, anxiety, and depression were analyzed. The factors like age, marital status, primary caretakers of the patient, social isolation, length of hospital stay, social relationships, number of frequent visits to the hospital/month, and the lifestyle of the patient have a significant association with the levels of stress, anxiety, and depression. Factors like monthly income and educational status were also found to be statistically significant with the stress levels, and length of intensive care unit (ICU) stay was significantly associated with the levels of anxiety. Conclusion: In conclusion, this study found a high prevalence of stress, anxiety, and depression among patients with chronic disease(s). Among all the chronic diseases, cardiovascular disease patients were found to have the highest prevalence of stress, anxiety, and depression. In addition, our study also identified several psychosocial factors that contribute to the development of these mental health conditions which exacerbate the present chronic condition of the patient. These findings highlight the importance of considering the impact of chronic disease on mental health problems.
- 16 August 2023
- Published by Springer Nature in Middle East Current Psychiatry
- Vol. 30 (1) , 1-14
Top Cited PapersOpen AccessPrevalence and correlates of stress, anxiety, and depression in patients with chronic diseases: a cross-sectional study
Background: Many chronic diseases, including diabetes, heart disease, cancer, and respiratory problems, can lead to emotional distress, anxiety, and depression among patients. Likewise, psychological conditions such as anxiety and depression can elevate the risk of developing chronic diseases. The objective of the study was to examine the prevalence of stress, anxiety, and depression in individuals with chronic diseases, as well as to identify the chronic disease with the highest prevalence among all chronic conditions and the factors associated with stress, anxiety, and depression. Results: In our study, the prevalence rate of stress, anxiety, and depression in patients having chronic diseases was found to be 68.7%, 51.1%, and 58.8%, respectively. The chronic diseases which are included in this study are cardiovascular diseases, metabolic disorders, cancer, respiratory disorders, degenerative disorders, chronic kidney disease, and chronic liver disorders. Among these diseases, cardiovascular disease patients were found to have the highest prevalence of stress, anxiety, and depression. The psychosocial determinants that can trigger stress, anxiety, and depression were analyzed. The factors like age, marital status, primary caretakers of the patient, social isolation, length of hospital stay, social relationships, number of frequent visits to the hospital/month, and the lifestyle of the patient have a significant association with the levels of stress, anxiety, and depression. Factors like monthly income and educational status were also found to be statistically significant with the stress levels, and length of intensive care unit (ICU) stay was significantly associated with the levels of anxiety. Conclusion: In conclusion, this study found a high prevalence of stress, anxiety, and depression among patients with chronic disease(s). Among all the chronic diseases, cardiovascular disease patients were found to have the highest prevalence of stress, anxiety, and depression. In addition, our study also identified several psychosocial factors that contribute to the development of these mental health conditions which exacerbate the present chronic condition of the patient. These findings highlight the importance of considering the impact of chronic disease on mental health problems.